Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea
· Delayed Price · Currency is KRW 9,710.00
-410.00 (-4.05%)
At close: Dec 5, 2025
Tdspharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Net Income | 3,281 | 3,718 | 4,688 | 3,456 | 2,063 | 1,351 | Upgrade
|
| Depreciation & Amortization | 720.06 | 668.59 | 1,022 | 1,266 | 1,230 | 1,208 | Upgrade
|
| Loss (Gain) From Sale of Assets | -440.92 | 88.76 | -0.2 | -6.24 | -11.14 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 52.24 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 103.11 | 67.36 | -3.05 | 8.06 | - | - | Upgrade
|
| Other Operating Activities | -1,128 | -187.02 | 363.21 | -24.36 | 361.45 | 378.68 | Upgrade
|
| Change in Accounts Receivable | -592.87 | 1,329 | -975.88 | -2,596 | 220.31 | -564.17 | Upgrade
|
| Change in Inventory | 652.91 | -658.37 | -330.23 | -268.36 | -199.46 | 88.17 | Upgrade
|
| Change in Accounts Payable | -736.13 | -727.35 | 46.36 | 971.97 | -53.58 | -221.16 | Upgrade
|
| Change in Other Net Operating Assets | 243.09 | -369.83 | -1,516 | 82.57 | 68.92 | -29.21 | Upgrade
|
| Operating Cash Flow | 2,102 | 3,929 | 3,294 | 2,942 | 3,680 | 2,212 | Upgrade
|
| Operating Cash Flow Growth | -42.39% | 19.29% | 11.94% | -20.04% | 66.36% | 3.62% | Upgrade
|
| Capital Expenditures | -1,207 | -715.7 | -213.82 | -625.42 | -200.89 | -229.12 | Upgrade
|
| Sale of Property, Plant & Equipment | 425.83 | 1.11 | 0.2 | 22.73 | 23.64 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -1.74 | -57.55 | -5.5 | - | -151.67 | Upgrade
|
| Investment in Securities | 968.88 | -12,500 | -4,527 | -515.58 | -1,478 | -2,631 | Upgrade
|
| Other Investing Activities | -2,988 | -14.57 | 28.39 | -93.91 | 15.55 | 63.22 | Upgrade
|
| Investing Cash Flow | -2,236 | -13,311 | -4,770 | -1,218 | -1,640 | -2,948 | Upgrade
|
| Long-Term Debt Issued | - | - | 300 | 675 | - | - | Upgrade
|
| Total Debt Issued | 360 | - | 300 | 675 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -1,000 | - | -1,330 | Upgrade
|
| Long-Term Debt Repaid | - | -320.63 | -124.81 | -85.06 | -51.2 | -43.05 | Upgrade
|
| Total Debt Repaid | -891.26 | -320.63 | -124.81 | -1,085 | -51.2 | -1,373 | Upgrade
|
| Net Debt Issued (Repaid) | -531.26 | -320.63 | 175.19 | -410.06 | -51.2 | -1,373 | Upgrade
|
| Issuance of Common Stock | - | 13,390 | - | - | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -2,706 | - | Upgrade
|
| Other Financing Activities | -0 | -619.33 | -0 | - | - | - | Upgrade
|
| Financing Cash Flow | -531.26 | 12,450 | 175.19 | -410.06 | -2,757 | -1,373 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.16 | 0.02 | -0.21 | -0.04 | - | - | Upgrade
|
| Net Cash Flow | -665.39 | 3,068 | -1,301 | 1,315 | -717.28 | -2,110 | Upgrade
|
| Free Cash Flow | 894.85 | 3,213 | 3,080 | 2,317 | 3,479 | 1,983 | Upgrade
|
| Free Cash Flow Growth | -71.54% | 4.34% | 32.92% | -33.40% | 75.45% | 11.05% | Upgrade
|
| Free Cash Flow Margin | 3.64% | 11.68% | 10.25% | 9.05% | 17.55% | 11.00% | Upgrade
|
| Free Cash Flow Per Share | 169.24 | 694.04 | 723.32 | 543.79 | 37650.19 | 19829.17 | Upgrade
|
| Cash Interest Paid | 222.04 | 262.18 | 280.43 | 195.09 | 84.97 | 157.08 | Upgrade
|
| Cash Income Tax Paid | 1,319 | 572.49 | 679.93 | 561.14 | 150.9 | 6.62 | Upgrade
|
| Levered Free Cash Flow | -579.05 | 2,396 | 2,428 | 1,052 | 2,720 | 1,189 | Upgrade
|
| Unlevered Free Cash Flow | -433.6 | 2,563 | 2,617 | 1,190 | 2,801 | 1,289 | Upgrade
|
| Change in Working Capital | -433 | -426.39 | -2,776 | -1,809 | 36.18 | -726.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.